About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT00178594

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Lead sponsor: The University of Texas Health Science Center, Houston•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Katherine Addy, RN, BSN, MPH

CONTACT

713-500-8352 Katherine.E.Addy@uth.tmc.edu

Daisy Garcia, RN, BSN

CONTACT

713-500-8386 daisy.r.garcia@uth.tmc.edu

Sponsors

Lead Sponsor

The University of Texas Health Science Center, Houston

This is an exploratory study involving blood coagulation assays in a select group of individuals receiving treatment for their congenital or acquired bleeding or clotting disorder at UTHealth Houston. The ROTEG is a newly developed coagulation analyzer which allows the continuous assessment of whole blood coagulation from the formation of the first fibrin fibers and activated platelets, to the formation of a three-dimensional whole blood clot until the eventual dissolution of the clot. This device will not be used as a diagnostic or procedure tool. No recommendations regarding interpretation of the results or implications for future treatment will be provided.

Age

0 - 98 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria: patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent Exclusion Criteria: poor venous access

Related studies

COMPLETEDPhase 1/2

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588 · Adeno-Associated Virus (AAV), Blood Coagulation Disorder, and more

The Effect of Human Prostate Tissue on Platelet Activation

NCT05059431 · Prostate Hyperplasia, Coagulation; Intravascular, and more

WITHDRAWNPhase 2

Prevention of Thromboembolic Events in Total Knee Replacement Patients

NCT03393481 · Thrombotic Disorders

Determination of Fibrin Activity in Plasma on STA-R® Prototype

NCT02856789 · Blood Coagulation Disorders, Thrombotic Disorders, and more

Education Program for Patients Receiving Oral Anticoagulation

NCT01339611 · Cardiovascular Disease, Venous Thromboses, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,000

Start dateOct 2002

Last updatedJan 9, 2025

Condition

Blood Coagulation Disorders, Inherited Thrombotic Disorder

Locations shown

The Univerisity of Texas Health Science Center at Houston

Houston, Texas

UT Physicians Women's Center-Texas Medical Center

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions